217 related articles for article (PubMed ID: 27551496)
1. Imeglimin prevents human endothelial cell death by inhibiting mitochondrial permeability transition without inhibiting mitochondrial respiration.
Detaille D; Vial G; Borel AL; Cottet-Rouselle C; Hallakou-Bozec S; Bolze S; Fouqueray P; Fontaine E
Cell Death Discov; 2016; 2():15072. PubMed ID: 27551496
[TBL] [Abstract][Full Text] [Related]
2. Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process.
Detaille D; Guigas B; Chauvin C; Batandier C; Fontaine E; Wiernsperger N; Leverve X
Diabetes; 2005 Jul; 54(7):2179-87. PubMed ID: 15983220
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes.
Hallakou-Bozec S; Vial G; Kergoat M; Fouqueray P; Bolze S; Borel AL; Fontaine E; Moller DE
Diabetes Obes Metab; 2021 Mar; 23(3):664-673. PubMed ID: 33269554
[TBL] [Abstract][Full Text] [Related]
4. Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications.
Yanai H; Adachi H; Hakoshima M; Katsuyama H
Biology (Basel); 2023 May; 12(5):. PubMed ID: 37237539
[TBL] [Abstract][Full Text] [Related]
5. Imeglimin normalizes glucose tolerance and insulin sensitivity and improves mitochondrial function in liver of a high-fat, high-sucrose diet mice model.
Vial G; Chauvin MA; Bendridi N; Durand A; Meugnier E; Madec AM; Bernoud-Hubac N; Pais de Barros JP; Fontaine É; Acquaviva C; Hallakou-Bozec S; Bolze S; Vidal H; Rieusset J
Diabetes; 2015 Jun; 64(6):2254-64. PubMed ID: 25552598
[TBL] [Abstract][Full Text] [Related]
6. Ganoderma atrum Polysaccharide Ameliorates Hyperglycemia-Induced Endothelial Cell Death via a Mitochondria-ROS Pathway.
Li WJ; Nie SP; Yao YF; Liu XZ; Shao DY; Gong DM; Cui SW; Phillips GO; He M; Xie MY
J Agric Food Chem; 2015 Sep; 63(37):8182-91. PubMed ID: 26323486
[TBL] [Abstract][Full Text] [Related]
7. Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using
Fauzi M; Murakami T; Fujimoto H; Botagarova A; Sakaki K; Kiyobayashi S; Ogura M; Inagaki N
Front Endocrinol (Lausanne); 2022; 13():1010825. PubMed ID: 36246910
[TBL] [Abstract][Full Text] [Related]
8. Exploring new mechanisms of Imeglimin in diabetes treatment: Amelioration of mitochondrial dysfunction.
Li Y; Lou N; Liu X; Zhuang X; Chen S
Biomed Pharmacother; 2024 Jun; 175():116755. PubMed ID: 38772155
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological profile and clinical efficacy of imeglimin hydrochloride (TWYMEEG
Nagamine J
Nihon Yakurigaku Zasshi; 2023; 158(2):193-202. PubMed ID: 36858505
[TBL] [Abstract][Full Text] [Related]
10. Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetes.
Pacini G; Mari A; Fouqueray P; Bolze S; Roden M
Diabetes Obes Metab; 2015 Jun; 17(6):541-545. PubMed ID: 25694060
[TBL] [Abstract][Full Text] [Related]
11. Melatonin prevents oxidative stress-mediated mitochondrial permeability transition and death in skeletal muscle cells.
Hibaoui Y; Roulet E; Ruegg UT
J Pineal Res; 2009 Oct; 47(3):238-52. PubMed ID: 19664004
[TBL] [Abstract][Full Text] [Related]
12. Short-and long-term administration of imeglimin counters cardiorenal dysfunction in a rat model of metabolic syndrome.
Lachaux M; Soulié M; Hamzaoui M; Bailly A; Nicol L; Rémy-Jouet I; Renet S; Vendeville C; Gluais-Dagorn P; Hallakou-Bozec S; Monteil C; Richard V; Mulder P
Endocrinol Diabetes Metab; 2020 Jul; 3(3):e00128. PubMed ID: 32704553
[TBL] [Abstract][Full Text] [Related]
13. Imeglimin lowers glucose primarily by amplifying glucose-stimulated insulin secretion in high-fat-fed rodents.
Perry RJ; Cardone RL; Petersen MC; Zhang D; Fouqueray P; Hallakou-Bozec S; Bolze S; Shulman GI; Petersen KF; Kibbey RG
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E461-70. PubMed ID: 27406738
[TBL] [Abstract][Full Text] [Related]
14. Respective effects of oxygen and energy substrate deprivation on beta cell viability.
Lablanche S; Cottet-Rousselle C; Argaud L; Laporte C; Lamarche F; Richard MJ; Berney T; Benhamou PY; Fontaine E
Biochim Biophys Acta; 2015; 1847(6-7):629-39. PubMed ID: 25868875
[TBL] [Abstract][Full Text] [Related]
15. Dependence of permeability transition pore opening and cytochrome C release from mitochondria on mitochondria energetic status.
Huang X; Zhai D; Huang Y
Mol Cell Biochem; 2001 Aug; 224(1-2):1-7. PubMed ID: 11693186
[TBL] [Abstract][Full Text] [Related]
16. NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition.
Javadov S; Choi A; Rajapurohitam V; Zeidan A; Basnakian AG; Karmazyn M
Cardiovasc Res; 2008 Jan; 77(2):416-24. PubMed ID: 18006455
[TBL] [Abstract][Full Text] [Related]
17. Nitric-oxide-induced necrosis and apoptosis in PC12 cells mediated by mitochondria.
Bal-Price A; Brown GC
J Neurochem; 2000 Oct; 75(4):1455-64. PubMed ID: 10987825
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy.
Fouqueray P; Pirags V; Diamant M; Schernthaner G; Lebovitz HE; Inzucchi SE; Bailey CJ
Diabetes Care; 2014 Jul; 37(7):1924-30. PubMed ID: 24722500
[TBL] [Abstract][Full Text] [Related]
19. The effect of permeability transition pore opening on reactive oxygen species production in rat brain mitochondria.
Akopova OV; Kolchynskayia LY; Nosar' VY; Smyrnov AN; Malisheva MK; Man'kovskaia YN; Sahach VF
Ukr Biokhim Zh (1999); 2011; 83(6):46-55. PubMed ID: 22364018
[TBL] [Abstract][Full Text] [Related]
20. Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress.
Zhao Y; Ye L; Liu H; Xia Q; Zhang Y; Yang X; Wang K
J Inorg Biochem; 2010 Apr; 104(4):371-8. PubMed ID: 20015552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
